These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7312107)

  • 21. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulins in epilepsy.
    Aarli JA
    Springer Semin Immunopathol; 1985; 8(1-2):5-28. PubMed ID: 2408350
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-IgA antibodies in epileptic patients with a low serum IgA concentration.
    Gilhus NE; Hammarström L
    Int J Immunopharmacol; 1991; 13(2-3):185-8. PubMed ID: 2071295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of monotherapy with phenytoin or carbamazepine on somatosensory evoked potentials in patients with newly diagnosed epilepsy].
    Rysz A
    Pol Tyg Lek; 1994 Jan 24-31; 49(4-5):79-81. PubMed ID: 8029147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenytoin vs carbamazepine in seizure disorder.
    Panagariya A
    J Assoc Physicians India; 1986 Aug; 34(8):608. PubMed ID: 3793691
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased depressant effect of phenytoin sodium as compared to carbamazepine on cortical excitability: a transcranial magnetic evaluation.
    Goyal V; Bhatia M; Behari M
    Neurol India; 2004 Jun; 52(2):224-7. PubMed ID: 15269477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological parameters in patients with epilepsy.
    Bostantjopoulou S; Hatzizisi O; Argyropoulou O; Andreadis S; Deligiannis K; Kantaropoulou M; Kazis A; Kyrazis G; Routsonis K
    Funct Neurol; 1994; 9(1):11-5. PubMed ID: 8082848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epileptic patients refractory to drug therapy.
    Paris L; Giardina M; Pacifici R; Pichini S; Zuccaro P; Sideri G
    Ital J Neurol Sci; 1991 Oct; 12(5):447-51. PubMed ID: 1955301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of phenytoin in vitro on normal human mononuclear cells and on human lymphoblastoid B cell lines of different Ig isotype specificities.
    Wangel AG; Arvilommi H; Jokinen I
    Immunobiology; 1985 Sep; 170(3):232-8. PubMed ID: 3932190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of antiepileptic drugs on immune system].
    Basta-Kaim A; Budziszewska B; Lasoń W
    Przegl Lek; 2008; 65(11):799-802. PubMed ID: 19205364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G in serum and cerebrospinal fluid from epileptic patients treated with phenytoin.
    Fossan GO; Aarli JA
    Eur Neurol; 1979; 18(5):322-7. PubMed ID: 527607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.
    Tate SK; Depondt C; Sisodiya SM; Cavalleri GL; Schorge S; Soranzo N; Thom M; Sen A; Shorvon SD; Sander JW; Wood NW; Goldstein DB
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5507-12. PubMed ID: 15805193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug induced IgA deficiency in epilepsy].
    Aarli JA
    Tidsskr Nor Laegeforen; 1976 Feb; 96(6):384-5. PubMed ID: 1257980
    [No Abstract]   [Full Text] [Related]  

  • 35. The reversibility of phenytoin-induced IgA deficiency.
    Gilhus NE; Aarli JA
    J Neurol; 1981; 226(1):53-61. PubMed ID: 6181216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of carbamazepine on serum immunoglobulin concentrations.
    Gilhus NE; Strandjord RE; Aarli JA
    Acta Neurol Scand; 1982 Aug; 66(2):172-9. PubMed ID: 7136483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy.
    Andrewes DG; Bullen JG; Tomlinson L; Elwes RD; Reynolds EH
    Epilepsia; 1986; 27(2):128-34. PubMed ID: 3956451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective neurometric studies during the beginning of carbamazepine and phenytoin therapy.
    Danner R; Lang H; Yale C
    Acta Neurol Scand; 1984 Apr; 69(4):207-17. PubMed ID: 6741455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monitoring plasma levels of some antiepileptic drugs (phenobarbital, diphenylhydantoin, carbamazepine) in the Lennox-Gastaut syndrome and in other forms of epilepsy (partial and secondary generalized) in childhood].
    Viani F; Gerna M; Riboldi A; Rossotti V; Morselli PL
    Riv Neurol; 1975; 45(2):189-98. PubMed ID: 809828
    [No Abstract]   [Full Text] [Related]  

  • 40. Respiratory disease in patients with epilepsy on single-drug therapy with carbamazepine or phenobarbital.
    Gilhus NE; Strandjord RE; Aarli JA
    Eur Neurol; 1982; 21(4):284-8. PubMed ID: 7117316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.